Name: Name:LIRIMILAST
Brand: AABLOCKS
SKU: AA00CNG9
Rating: 90 (10 reviews)

Catalog No.: AA00CNG9

329306-27-6 | LIRIMILAST

Pack Size： 2mg

Purity： 98%

in stock

$313.00 $219.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA00CNG9

Chemical Name: LIRIMILAST

CAS Number: 329306-27-6

Molecular Formula: C17H12Cl2N2O6S

Molecular Weight: 443.2580

MDL Number: MFCD09837901

SMILES: NC(=O)Nc1c(oc2c1ccc(c2)OS(=O)(=O)C)C(=O)c1ccc(cc1Cl)Cl

Properties

Complexity: 715

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 28

Hydrogen Bond Acceptor Count: 6

Hydrogen Bond Donor Count: 2

Isotope Atom Count: 0

Rotatable Bond Count: 5

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 4

Literature fold

Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.

Journal: Bioorganic & medicinal chemistry letters20130801

Title: Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.

Journal: Journal of medicinal chemistry20111208

Title: Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).

Journal: Pulmonary pharmacology & therapeutics20030101

Title: Grootendorst DC, et al. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). Pulm Pharmacol Ther. 2003;16(6):341-7.

Title: Peter Norman. PDE4 inhibitors: sustained patenting activity as leading drugs near the market. Exp. Opin. Ther. Patents (2000) 10(9):1415-1427.

Building Blocks More >